Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Brenner

Showing results (221-230 of 231) with videos related to

Pageof 24
Sort By:
Der Anaesthesist|February 1, 2018
Bacterial sepsis : Diagnostics and calculated antibiotic therapyD C Richter, A Heininger, T Brenner, et al.
Der Anaesthesist|October 6, 2017
[Bacterial sepsis : Diagnostics and calculated antibiotic therapy]D C Richter, A Heininger, T Brenner, et al.
BMC Health Services Research|November 7, 2024
Harmonizing data across the accelerating colorectal cancer screening and follow-up through implementation science (ACCSIS) program to enhance data quality and promote data sharingSujha Subramanian, Sarah Kobrin, Sonja Hoover, et al.
Implementation Science Communications|September 20, 2023
Implementation strategies in the Exploration and Preparation phases of a colorectal cancer screening intervention in community health centersRenée M Ferrari, Jennifer Leeman, Alison T Brenner, et al.
Cancer Causes & Control : CCC|April 3, 2026
Scaling what works: a collaborative capacity-building program tailored to optimize resources and scale evidence-based interventions for cancer prevention and controlMary Wangen, Jingle Xu, Amy Tran, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|May 2, 2020
[S3 Guideline Sepsis-prevention, diagnosis, therapy, and aftercare : Long version]F M Brunkhorst, M A Weigand, M Pletz, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|March 19, 2020
[S3 guideline sepsis-prevention, diagnosis, treatment, and aftercare : Summary of the strong recommendations]F M Brunkhorst, M A Weigand, M Pletz, et al.
Journal of Autoimmunity|December 31, 2013
A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravisP Zisimopoulou, P Evangelakou, J Tzartos, et al.
Journal of Neuroimmunology|May 31, 2015
MuSK autoantibodies in myasthenia gravis detected by cell based assay--A multinational studyA I Tsonis, P Zisimopoulou, K Lazaridis, et al.
Journal of Neuroimmunology|March 6, 2016
Titin antibodies in "seronegative" myasthenia gravis--A new role for an old antigenC Stergiou, K Lazaridis, V Zouvelou, et al.
Pageof 24

Showing results (221-230 of 231) with videos related to

Sort By:
Pageof 24
Der Anaesthesist|February 1, 2018
Bacterial sepsis : Diagnostics and calculated antibiotic therapyD C Richter, A Heininger, T Brenner, et al.
Der Anaesthesist|October 6, 2017
[Bacterial sepsis : Diagnostics and calculated antibiotic therapy]D C Richter, A Heininger, T Brenner, et al.
BMC Health Services Research|November 7, 2024
Harmonizing data across the accelerating colorectal cancer screening and follow-up through implementation science (ACCSIS) program to enhance data quality and promote data sharingSujha Subramanian, Sarah Kobrin, Sonja Hoover, et al.
Implementation Science Communications|September 20, 2023
Implementation strategies in the Exploration and Preparation phases of a colorectal cancer screening intervention in community health centersRenée M Ferrari, Jennifer Leeman, Alison T Brenner, et al.
Cancer Causes & Control : CCC|April 3, 2026
Scaling what works: a collaborative capacity-building program tailored to optimize resources and scale evidence-based interventions for cancer prevention and controlMary Wangen, Jingle Xu, Amy Tran, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|May 2, 2020
[S3 Guideline Sepsis-prevention, diagnosis, therapy, and aftercare : Long version]F M Brunkhorst, M A Weigand, M Pletz, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|March 19, 2020
[S3 guideline sepsis-prevention, diagnosis, treatment, and aftercare : Summary of the strong recommendations]F M Brunkhorst, M A Weigand, M Pletz, et al.
Journal of Autoimmunity|December 31, 2013
A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravisP Zisimopoulou, P Evangelakou, J Tzartos, et al.
Journal of Neuroimmunology|May 31, 2015
MuSK autoantibodies in myasthenia gravis detected by cell based assay--A multinational studyA I Tsonis, P Zisimopoulou, K Lazaridis, et al.
Journal of Neuroimmunology|March 6, 2016
Titin antibodies in "seronegative" myasthenia gravis--A new role for an old antigenC Stergiou, K Lazaridis, V Zouvelou, et al.
Pageof 24